Q4 2018 Corindus Vascular Robotics Inc Earnings Call
שיחת ועידה Corindus Vascular Robotics Inc
Corindus Vascular Robotics Inc Conference call will be held on 12/03/2019. During the earnings conference call's session Corindus Vascular Robotics Inc will provide updated information and financial status.
Conference call service enable to conduct an online meeting with several participates at the same time without leaving the room. Earnings call use teleconference platform to conduct an online meeting between the management of a public company, analysts, investors and the media to discuss the financial results during a given reporting period
In order to join the earnings online meeting, contact Corindus Vascular Robotics Inc for the information on connecting using web conferencing or bridge number and PIN code
Schedule an online meeting with QCONF conference service and get free conference bridge.
We design, manufacture and sell precision vascular robotic-assisted systems for use in interventional vascular procedures (the "CorPath® System"). Our first and current product, the CorPath 200 System, is the only vascular robotic system cleared by the U.S. Food and Drug Administration ("FDA") to bring precision and accuracy to stent placement in percutaneous coronary intervention ("PCI") procedures. During the procedure, the interventional cardiologist sits at a radiation-shielded interventional cockpit to advance stents and guidewires with millimeter-by-millimeter precision. The interventional cockpit allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. The CorPath System brings robotic precision to radial and complex PCI procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement with manual PCI procedures.קרא עוד שיחת ועידה